CEP

From OncoWiki
Jump to: navigation, search

Indication

Relapsed, refractory HD

Regimen

CCNU 80mg/m2 PO day 1
Etoposide 100mg/m2 PO days 1-5
Prednimustine 60mg/m2 days 1-5

For relapses from MOPP/ABVD less than 12 months remission; 40% CR, 20% 5 yr survival

References

Santoro et al. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. Semin Oncol 13 (Supp 1) (1986): 23-26